Prognostic value of D-dimer in patients undergoing myocardial infarction in the context of a new coronavirus infection pandemic

In conditions of new coronavirus pandemic and high prevalence of myocarditis, myopericarditis, the issues of differential diagnosis, especially in patients who had previously undergone myocardial infarction, appear to be relevant. Against the background of COVID-19 both recurrent acute coronary disease and myocarditis, or myopericarditis are possible, and the differential diagnosis is significantly complicated by the similarity of clinical picture (pain in the heart area (not always typical), increased titers of cardiac troponins). Particular difficulties in diagnosis arise in patients who have undergone myocardial infarction, are in a coma and have unstable hemodynamics, since the detection of zones of local hypo- or akinesis on EchoCG has no proper diagnostic value; changes on ECG can be ambiguous; and the absolute majority of hospitals that provide care to COVID-19 patients have no possibilities of making MRI with gadolinium. In such cases, additional diagnostic methods may be helpful in making a definitive diagnosis. In such cases, additional diagnostic methods may be helpful in making a definitive diagnosis. The most available and well-studied laboratory indicator is D-dimer, which is a marker of hypercoagulation syndrome, however, some scientists also considered it as a marker of necrosis in myocardial infarction. This review shows the advantages and disadvantages of D-dimer in the diagnosis of acute coronary syndrome; the possibility of its use in patients with coronavirus infection, who had previously undergone myocardial infarction; the prospects for further research on this issue are outlined. The combined use of D-dimer test with electrocardiography, echocardiography, and clinical manifestations in patients with coronavirus infection to diagnose recurrent myocardial infarction was substantiated.

1. Serezhina E.K., Obrezan A.G. Cardiovascular pathology in patients with COVID-19. Kardiologiia. 2020;60(8):23-26 (in Russ.). DOI: 10.18087/cardio.2020.8.n1215. EDN: CLXLAE.

2. Tishkov S.P., Dotsenko E.A., Platoshkin E.N., Rebeko E.S., Tireshchenko E.G., Sazonov S.N., Nikulina N.A., Rusak T.V., et al. Pseudo-coronary variant of the course of myocarditis. Health and Ecology Issues. 2020;(4):128-134 (in Russ.). DOI: 10.51523/2708-6011.2020-17-4-18. EDN: TLNBJJ.

3. Gomboeva S.B., Ryabov V.V., Shelkovnikova T.A., Usov V.Yu., Markov V.A., Karpov R.S. Case of pseudocoronary presentation of myocarditis with ST segment elevation.Russian Journal of Cardiology. 2016;(11):95-96 (in Russ.). DOI: 10.15829/1560-4071-2016-11-95-96. EDN: XQPRKX.

4. Kanorskii S.G. COVID-19 and the heart: direct and indirect impact. Kuban Scientific Medical Bulletin. 2021;28(1):16-31 (in Russ.). DOI: 10.25207/1608-6228-2021-28-1-16-31. EDN: WZLLGS

5. Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5): 911-915. DOI: 10.1002/ejhf.1828.

6. Nematzoda O., Gaibov A.D., Kalmykov E.L., Baratov A.K. COVID-19-related arterial thrombosis. Avicenna Bulletin. 2021;23(1):85-94 (in Russ.). DOI: 10.25005/2074-0581-2021-23-1-85-94. EDN: APPDJJ.

7. Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study.Intensive Care Med. 2020;46(6):1089-1098. DOI: 10.1007/s00134-020-06062-x.

8. Mehra M.R., Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link? JACC Heart Fail. 2020;8(6):512-514. DOI: 10.1016/j.jchf.2020.03.004.

9. Dzhioeva O.N., Drapkina O.M. Heart ultrasound in COVID-19. Arte-rial'naya gipertenziya. 2020;26(3):270-276. DOI: 10.18705/1607-419X-2020-26-3-270-276.

10. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7): 934-943. DOI: 10.1001/jamainternmed.2020.0994.

11. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. DOI: 10.1016/S0140-6736(20)30566-3.

12. Folsom A.R., Gottesman R.F., Appiah D., Shahar E., Mosley T.H. Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study. Stroke. 2016;47(1):18-23. DOI: 10.1161/STROKEAHA.115.011035.

13. Lin K.Y., Chen H.C., Jiang H., Wang S.Y., Chen H.M., Wu Z.Y., Jiang F., Guo Y.S., et al. Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention. BMC Nephrol. 2020;21(1):90. DOI: 10.1186/s12882-020-01743-7.

14. Induruwa I., Moroi M., Bonna A., Malcor J.D., Howes J.M., Warburton E.A., Farndale R.W., Jung S.M. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation. J Thromb Haemost. 2018;16(2):389-404. DOI: 10.1111/jth.13919.

15. Weitz J.I., Fredenburgh J.C., Eikelboom J.W. A Test in Context: D-Dimer. J Am Coll Cardiol. 2017;70(19):2411-2420. DOI: 10.1016/j.jacc.2017.09.024.

16. Weng L.C., Tang W., Rich S.S., Smith N.L., Redline S., O'Donnell C.J. Basu S., Reiner A.P., et al. A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups. Thromb Res. 2014;134(2):462-467. DOI: 10.1016/j.thromres.2014.05.018

17. Voitsekhovsky V.V., Landyshev Yu.S., Tseluiko S.S., Zabolotskikh T.V. Haemorrhagic syndrome in clinical practice. Blagoveshchensk: Amur State Medical Academy, 2014. 256 p. (in Russ.). EDN: SJTHIN.

18. Acute myocardial infarction with elevation of the ST segment of the electrocardiogram. Clinical recommendations. Moscow: Ministry of Health of the Russian Federation, 2020. URL: http://cr.rosminzdrav.ru/#!/recomend/135.

19. Acute coronary syndrome without ST segment elevation electrocardiogram. Clinical recommendations. Moscow: Ministry of Health of the Russian Federation, 2020. URL: http://cr.rosminzdrav.ru/#!/recomend/1016.

20. Di Castelnuovo A., de Curtis A., Costanzo S., Persichillo M., Olivieri M., Zito F., Donati M.B., de Gaetano G., et al. MOLI-SANI Project Investigators. Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica. 2013;98(9):1476-1480. DOI: 10.3324/haematol.2012.083410.

21. Panina A.V., Puchinyan N.F., Dovgalevskyi Y.P., Furman N.V., Dolotovskaya P.V., Malinova L.I. Risk of recurrent thrombotic events in patients with acute coronary syndrome and high plasma levels of D-dimer. Cardiovascular Therapy and Prevention. 2013;12(4):26-31 (in Russ.). DOI: 10.15829/1728-8800-2013-4-26-31. EDN: RBFUFV.

22. Kostrova O.Yu., Stomenskaya I.S., Timofeeva N.Yu., Struchko G.Yu., Bubnova N.V., Chesnokova A.E., Samushkina A.V. Troponin I and D-dimer in diagnostics of myocardial infarction. Terapia. 2019;5(7):64-68 (in Russ.). DOI: 10.18565/therapy.2019.7.64-68. EDN: KVEBFC.

23. Bulashova O.V., Malkova M.I. Significance of D-dimer in the diagnosis and prognosis of thromboembolic complications in cardiac patients. Prakticheskaya meditsina. 2012;60(5):81-84 (in Russ.). EDN: PCNXBP.

24. Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V., Pesenti A., Peyvandi F., et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738-1742. DOI: 10.1111/jth.14850.

25. Shi S., Nie B., Chen X., Cai Q., Lin C., Zhao G., Zhang X. Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China. J Clin Lab Anal. 2021;35(1):e23692. DOI: 10.1002/jcla.23692.

26. Murkamilov I.Т. The relationship between markers of inflammation and the morphofunctional state of erythrocytes and platelets in the new coronavirus disease 2019 (COVID-19). Vestnik Kyrgyzsko-Rossijskogo Slavjanskogo universiteta. 2021;21(1):43-52 (in Russ.). EDN: HABLNV.

27. Golukhova E.Z., Rybka M.M., Klyuchnikov I.V., Mamalyga M.L., Slivneva I.V., Zhelikhazeva M.V., Ramnenok T.V. Options for the course of COVID-19. Creative Cardiology. 2021;15(1):32-47. (in Russ.). DOI: 10.24022/1997-3187-2021-15-1-32-47. EDN: NTCCQN.

28. Yavelov I.S., Knyazev A.S., Dobrovolsky A.B., Gratsiansky N.A. Early discontinuation of fondaparinux in low-risk patients hospitalized with non-ST-elevation acute coronary syndrome: markers of hemostasis activation and in-hospital outcomes.Russian Journal of Cardiology. 2015;(3):43-51 (in Russ.). DOI: 10.15829/1560-4071-2015-3-43-51. EDN: TNEARL.

29. Christersson C., Lindahl B., Berglund L., Siegbahn A., Oldgren J. The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients. Ups J Med Sci. 2017;122(4):224-233. DOI: 10.1080/03009734.2017.1407849.

30. Hansen C.H., Ritschel V., Andersen G.Ø., Halvorsen S., Eritsland J., Arnesen H., Seljeflot I. Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost. 2018;24(7):1088-1094. DOI: 10.1177/1076029618764847.

31. Choi S., Jang W.J., Song Y.B., Lima J.A., Guallar E., Choe Y.H., Hwang J.K., Kim E.K., et al. D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study. PLoS One. 2016;11(8):e0160955. DOI: 10.1371/journal.pone.0160955.

32. Gao R., Wang J., Zhang S., Yang G., Gao Z., Chen X. The Value of Combining Plasma D-Dimer and Endothelin-1 Levels to Predict No-Reflow After Percutaneous Coronary Intervention of ST-Segment Elevation in Acute Myocardial Infarction Patients with a Type 2 Diabetes Mellitus History. Med Sci Monit. 2018;24:3549-3556. DOI: 10.12659/MSM.908980.

33. Karamysheva E.I., Markova L.I., Podgornaja E.M. D-dimer as an indicator of reperfusion in patients with acute ST-elevation myocardial infarction. Eastern European Scientific Journal. 2018;37(9-2):30-33 (in Russ.). EDN: ZDPBQD.

34. Yu T., Jiao Y., Song J., He D., Wu J., Sun Z., Sun Z. Hospital mortality in acute coronary syndrome: adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study. BMC Cardiovasc Disord. 2019;19(1):252. DOI: 10.1186/s12872-019-1239-4

35. Zakai N.A., McClure L.A., Judd S.E., Kissela B., Howard G., Safford M., Cushman M. D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Thromb Haemost. 2017;117(3): 618-624. DOI: 10.1160/TH16-07-0519.

36. Liu C., Ning Y., Chen X., Zhu Q. D-Dimer level was associated with prognosis in metastatic colorectal cancer: A Chinese patients based cohort study. Medicine (Baltimore). 2020;99(7):e19243. DOI: 10.1097/MD.0000000000019243.

37. Zhou Q., Xue Y., Shen J., Zhou W., Wen Y., Luo S. Predictive values of D-dimer for the long-term prognosis of acute ST-segment elevation infarction: A retrospective study in southwestern China. Medicine (Baltimore). 2020;99(16):e19724. DOI: 10.1097/MD.0000000000019724.

38. Ammirati E., Veronese G., Brambatti M., Merlo M., Cipriani M., Potena L. Sormani P., Aoki T., et al. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2019;74(3):299-311. DOI: 10.1016/j.jacc.2019.04.063.

39. Patriki D., Gresser E., Manka R., Emmert M.Y., Lüscher T.F., Heidecker B. Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging. JACC Heart Fail. 2018;6(7):573-579. DOI: 10.1016/j.jchf.2018.03.002.

40. Coronado M.J., Bruno K.A., Blauwet L.A., Tschöpe C., Cunningham M.W., Pankuweit S. van Linthout S., Jeon E.S., et al. Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis. J Am Heart Assoc. 2019;8(2):e008968. DOI: 10.1161/JAHA.118.008968.

41. Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12: 670-680. DOI: 10.1038/nrcardio.2015.108.